OptoSeeker Extends Instruments Toward AI-Assisted Wet Labs
36氪 reports that OptoSeeker is combining self-developed life-science instruments, AI models, laboratory automation, hardware-software coordination, and data capabilities to explore intelligent wet-lab solutions. Its commercial OptoBot 1000 integrates optical tweezers, microfluidics, imaging, and automated control, while the company is also developing a life-science agent and has reported partnerships spanning AI models, sequencing, and omics services. The report describes deployments and financing, but its single-source, company-profile format leaves performance and commercialization claims unverified.
OptoSeeker illustrates how life-science instrument companies are extending AI capabilities into physical experiment execution, where throughput, precise manipulation, reliable data capture, and workflow integration remain important engineering requirements.
当人工智能加速走进生物实验室,一类长期被低估的底层硬件与系统工程能力,正在重塑行业估值逻辑。
随着 AI 在蛋白质结构预测、分子设计和药物发现等领域接连突破,AI for Biology 已成为科技投资的核心方向。但当模型能够生成海量科学假设后,产业瓶颈随之转移到物理世界:谁来完成真实世界的湿实验验证?
AI 能够快速生成海量蛋白质结构与候选分子,但真实世界的生物实验仍受到实验通量、检测效率和物理操作能力的限制
一个日趋清晰的行业共识是:AI 生物科技的下半场,卡点不再只是算力与算法,而是真实实验的“交付产能”。一套真正能跑通商业闭环的自主实验室,必须同时跨过规模化执行、系统通用性和高质量数据沉淀这三道工程门槛。
#OptoSeeker#OptoBot 1000#DropletBot#OptoNeuroBot#Danaher#BioMap#MGI Tech#AkesoBio